Clinical trials
Follow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Certmedica International GmbH
Aschaffenburg, Bavaria/Bayern, Germanycertmedica.com ↗
- Ownership
- Private
- Employees
- ~50
- Development stage
- Other
01
Overview
Certmedica has completed multiple clinical trials demonstrating efficacy of its polyglucosamine-based medical device (formoline L112) for reducing cholesterol absorption and supporting weight management. Additional studies include artificial saliva spray for xerostomia in diabetes type II patients.[3]
- Therapeutic areas
- EndocrinologyCardiovascularMetabolic Disorders
- Modalities
- Medical devicesNutritional supplementsCosmetics
- Industry
- Therapeutic Medical Devices
Beyond the preview
Go deeper on Certmedica International GmbH.
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Licensing & deals
Explore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Trace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Compare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Explore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Connect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Certmedica International GmbH.